Jessica Knight
Foot & Ankle Surgery · Arlington Heights, ILNPI 1942565593
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. Stryker accounts for 82.0% of it on its own, with 7 other manufacturers making up the rest. Among foot & ankle surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 146 payments — averaging $129.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$15K
- Synthes GmbH$1K
- Medwest Associates$1K
- Treace Medical Concepts, Inc.$422
- Medline Industries LP$104
- Medical Device Business Services, Inc.$95
- plus $56 from 2 others
What the payments were for
- Consulting fees$1,0005%
- Travel & lodging$7,46840%
- Food & beverage$9,19449%
- Education$1,2006%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 133 | $15,457 |
| Synthes GmbH | 3 | $1,496 |
| Medwest Associates | 2 | $1,231 |
| Treace Medical Concepts, Inc. | 3 | $422 |
| Medline Industries LP | 1 | $104 |
| Medical Device Business Services, Inc. | 1 | $95 |
| Gilead | 2 | $38 |
| Bioventus LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$2,643
- PRIME SERIES$1,176
- HOFFMANN$1,061
- CITREFIX$919
- INFINITY$772
- STAR$666
- PROPHECY$603
- ORTHOLOC 2 LAPIFUSE$453
- EASYFUSE$449
- SALVATION$398
- VARIAX$393
- Lapiplasty System$336
- AUGMENT INJECTABLE$308
- 7 X 23MM CITRELOCK IMPLANT$171
- Actishield$171
- AXS INFINITY LS$169
- ICONIX$169
- OMEGA$169
- BIOSTEON INTERFERENCE SCREWS$169
- BIOSTEON INTRALINE$169
How this compares
$18,861 in reported general payments places this provider in the 90th percentile of 555 foot & ankle surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 42 | $896 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 56 | $416 |
| Cefadroxil | 54 | $408 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $318 |
| Methylprednisolone | 33 | $207 |
| Ketoconazole | 12 | $131 |
| Terbinafine Hcl | 17 | $113 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $106 |
| Naproxen | 16 | $51 |
| Tramadol Hcl | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Arlington Heights
- Gene ChoiArlington Heights$17K
- Douglas PacaccioRockford$4.1M
- Anand VoraLibertyville$3.2M
- Lowell WeilMount Prospect$2.2M
- Matthew SorensenAlgonquin$1.1M
- Edgardo Rodriguez CollazoChicago$755K
- David GarrasOrland Park$658K
- Patrick McEneaneyCary$570K
- Brian BurgessNaperville$488K
- Kyle PearsonMorris$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.